# COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials

> **NCT02723981** · PHASE4 · WITHDRAWN · sponsor: **IHF GmbH - Institut für Herzinfarktforschung**

## Conditions studied

- Stable Angina
- Unstable Angina
- STEMI
- NSTEMI
- Coronary Disease

## Interventions

- **DEVICE:** COMBO-Stent
- **DRUG:** Clopidogrel, Vitamin K Antagonist, Rivaroxaban, Dabigatran
- **DEVICE:** Any drug eluting stent oder bare metal sent
- **DRUG:** ASA, Clopidogrel, Vitamin K Antagonist, Rivaroxaban, Dabigatran

## Key facts

- **NCT ID:** NCT02723981
- **Lead sponsor:** IHF GmbH - Institut für Herzinfarktforschung
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-04
- **Primary completion:** 2018-05
- **Final completion:** 2018-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Regulatory authority approval for the initial study design could not be obtained
- **Last updated:** 2017-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02723981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02723981, "COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02723981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*